Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Microorganisms|March 6, 2021
Deep Ultraviolet Light-Emitting Diode Light Therapy for <i>Fusobacterium nucleatum</i>Soichiro Fukuda, Shunsuke Ito, Jun Nishikawa, et al.
The Prostate|October 7, 2025
Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3-5 LesionsTakanori Tokunaga, Mitsuaki Nishioka, Keita Kobayashi, et al.
Molecular Carcinogenesis|July 11, 2007
Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumorsKazuo Hashimoto, Yoshihisa Shimizu, Yutaka Suehiro, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2020
What is the best wavelength for the measurement of hemolysis index?Akiyo Ishiguro, Mitsuaki Nishioka, Akihiro Morishige, et al.
Microorganisms|September 5, 2019
Clinicopathologic Characteristics of Epstein-Barr Virus-Associated Gastric Cancer Over the Past Decade in JapanAyaka Yanagi, Jun Nishikawa, Kanami Shimokuri, et al.
Cancers|November 12, 2014
Epstein-barr virus in gastric carcinomaJun Nishikawa, Hironori Yoshiyama, Hisashi Iizasa, et al.
Genes, Chromosomes & Cancer|February 9, 2010
TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancerToshiyuki Okada, Yutaka Suehiro, Koji Ueno, et al.
International Journal of Oncology|September 2, 2014
A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypesRyouichi Tsunedomi, Shoichi Hazama, Yusuke Fujita, et al.
Oncology Letters|October 16, 2019
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trialsHiromichi Maeda, Shoichi Hazama, Shigeyoshi Iwamoto, et al.
Journal of Translational Medicine|June 21, 2014
Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancerYoshitaro Shindo, Shoichi Hazama, Yoshinari Maeda, et al.
Pageof 13